Business
Plans for a new larger state-of-the-art facility
Plans for a new larger state-of-the-art facility.
About this update from Hvivo Plc
[{"type":"text","content":"\n\n\nhVIVO plc\n(\"hVIVO\" or the \"Company\")\n \nPlans for a new larger state-of-the-art facility to meet growing demand\n \n· Capacity increase to 50 quarantine beds with optionality to expand to 70\n· Expansion of laboratory services to include cutting edge labs\n· Largely funded by multiple hVIVO clients\n \nhVIVO plc (AIM & Euronext: HVO), the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its plans for a new consolidated facility at the fast-growing life sciences hub in Canary Wharf, London. The expansion, largely funded by hVIVO clients, comes in response to the Company's growing orderbook and increasing demand for its human challenge trial services.\n \nA world class facility with further expansion capability\nThe upcoming state-of-the-art facility will serve as a comprehensive site, housing quarantine bedrooms, advanced laboratories, an outpatient unit, and corporate offices, all conveniently spread across two floors. The facility will contain 50 quarantine beds, with potential expansion capabilities to accommodate up to 70 quarantine beds in the future. This highly secure and specialised facility will also enable hVIVO to conduct even more challenge trials concurrently. Additionally, the on-site outpatient unit will facilitate Phase II and III field trials. The cutting-edge virology and immunology laboratories will significantly increase sample throughput and diversify hVIVO's services, expanding its capacity to work with a broader range of pathogens.\n \nTimely completion and seamless transition\nThe new facility's first phase is anticipated to reach completion in Q1 2024, with the full site expected to be operational by Q2 2024. hVIVO's current Whitechapel and Queen Mary Bioenterprises Centre (QMB) clinics will close in 2024 but will remain fully operational throughout this transition, ensuring uninterrupted service delivery to the Company's clients. Additionally, hVIVO's Plumbers Row and Manchester FluCamp screening facilities and outpatient unit will continue to serve as convenient locations for prospective volunteers.\n \nPositive financial impact and optimised operations\nThe increase in demand from multiple clients seeking to accelerate their studies and ...